The UK High Court holds that there can only be one set of licencing terms that are fair, reasonable and non-discriminatory (FRAND) for a given situation, FRAND royalties should be based on a common portfolio benchmark rate for all licensees, and in this case a licence restricted to one jurisdiction is not FRAND. It is […]
Small and medium sized companies in Coventry & Warwickshire have the opportunity to obtain grants of typically between £25-50,000 to assist with costs relating to intangible assets (such as patents, trade marks and copyright), relating to seconded personnel and relating to support services. This is aimed at advancing the development of innovative products and services […]
On Friday 10 February 2017, Italy became the latest country to ratify the UPCA, bringing the total number of ratifications to twelve. As ten other non-mandatory countries, plus France, have already ratified the Agreement (listed here), the ratification of Italy was not required to initiate the UPC. However, with Italy being the fourth largest economy […]
Following UK Prime Minister, Theresa May’s speech of 17 January 2017 and subsequent comments, we now have greater clarity regarding the “bespoke” nature of the UK’s leaving of the European Union. There is no doubt, following her speech, that the intent of the UK executive government is that the UK will no longer be a […]
An official statement from the Unified Patent Court (UPC) website, published today (found here), has outlined a rough timetable for the UPC becoming operational. If all continues as expected, the Agreement on the Unified Patent Court (UPCA) and the Court itself should be up and running in December 2017. This would mean that the ‘Unitary […]
The use of numerical ranges and values to accurately describe the amount of ingredients present in a composition or formulation is a widely used approach in patent specifications, especially in the field of pharmaceuticals and formulation chemistry. Patentees need to clearly define the limits of various active ingredients, excipients and the like in order to […]